STOCK TITAN

Health Catalyst Stock Price, News & Analysis

HCAT Nasdaq

Welcome to our dedicated page for Health Catalyst news (Ticker: HCAT), a resource for investors and traders seeking the latest updates and insights on Health Catalyst stock.

Health Catalyst, Inc. (Nasdaq: HCAT) is a provider of data and analytics technology and services for healthcare organizations, and its news flow reflects this focus on data-informed healthcare improvement. Company announcements frequently highlight developments in its cloud-based technology ecosystem, Health Catalyst Ignite™, AI-enabled analytics solutions, and expert services that support measurable clinical, financial, and operational outcomes.

Investors and healthcare professionals following HCAT news will see regular earnings releases and financial updates, including quarterly results, segment performance for Technology and Professional Services, and guidance on total revenue and adjusted EBITDA. These releases are often accompanied by conference call details and references to key risk factors discussed in the company’s SEC filings.

Health Catalyst news also covers client partnerships and platform deployments. Recent examples include UnityPoint Health’s migration from a legacy Health Catalyst data platform to the modern Ignite Data and Analytics platform, and CyncHealth Nebraska’s expanded partnership using the company’s Ninja Universe technology to improve Continuity of Care Documents across a statewide health information exchange.

Another recurring theme in HCAT news is security and compliance milestones. The company has announced HITRUST r2 Certification for offerings such as Twistle, Lumeon, and Upfront, underscoring its focus on information protection for healthcare data. Governance and leadership updates, including the appointment of a President and Chief Operating Officer, board additions, and the planned retirement of the CEO, are disclosed through press releases and 8-K filings.

Visitors to this HCAT news page can review these announcements in one place, from investor conference participation and Catalyst Awards recognition of client achievements to regulatory and corporate governance updates, providing a consolidated view of Health Catalyst’s ongoing activities in healthcare data and analytics.

Rhea-AI Summary

Health Catalyst (HCAT) has acquired ARMUS Corporation, a Silicon Valley firm specializing in clinical registry development and data management. This acquisition aims to enhance Health Catalyst's Clinical Quality and Outsourced Services offerings by integrating ARMUS's technology with its own Data Operating System (DOS™). Health Catalyst expects this strategic move to streamline operations for healthcare organizations and deliver significant financial savings. The collaboration promises to advance data abstraction and registry reporting capabilities, addressing the increasing demand for data-driven insights in healthcare.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.63%
Tags
-
Rhea-AI Summary

Health Catalyst, Inc. (HCAT) reported Q1 2022 financial results, showing a 22% year-over-year revenue increase to $68.1 million, exceeding guidance. Adjusted EBITDA reached $671,000, a significant turnaround from a $(837,000) loss a year prior. Technology revenue rose 25% to $42.2 million, while professional services revenue grew 17% to $25.9 million. The net loss decreased by 21% to $22.5 million, highlighting improved operational efficiency amid labor market challenges. The company aims for continued growth and stability as it marks its third year as a public entity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.63%
Tags
-
Rhea-AI Summary

Health Catalyst (Nasdaq: HCAT) will release its first quarter 2022 operating results on May 10, 2022, after market close. A conference call to discuss these results is scheduled for the same day at 5 p.m. E.T. Participants can join by dialing (877) 295-1104 for U.S. calls or (470) 495-9486 for international calls, using participant code 2480316. The event will also be streamed live online, with a replay available for approximately 90 days. Health Catalyst specializes in data and analytics technology for healthcare organizations, helping them improve clinical and operational outcomes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.71%
Tags
conferences earnings
Rhea-AI Summary

Health Catalyst (Nasdaq: HCAT) announced a strategic partnership with Tallahassee Memorial HealthCare (TMH) on March 10, 2022. This multi-year collaboration aims to implement a scalable analytics platform to consolidate TMH's data sources, supporting clinical improvement in areas like infection rates and patient readmissions. TMH will utilize Health Catalyst’s Data Operating System (DOS™) and Analytic Accelerators for enhanced data access and analytics efficiency. The partnership focuses on improving patient outcomes and operational excellence, marking a significant step toward data-informed healthcare transformation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.44%
Tags
none
-
Rhea-AI Summary

Health Catalyst (HCAT) reported strong Q4 and full-year 2021 results, exceeding revenue and Adjusted EBITDA guidance. Q4 revenue reached $64.7M, a 21% increase YoY, while full-year revenue grew 28% to $241.9M. Technology revenue rose 34% to $147.7M, and professional services revenue increased by 20% to $94.2M. Despite a net loss of $48.99M in Q4, the company's dollar-based retention rate improved to 112%. Health Catalyst continues to prioritize consistent performance as a public entity, marking its achievements amid a challenging macro environment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.69%
Tags
none
-
Rhea-AI Summary

Health Catalyst (Nasdaq: HCAT) announced its partnership with Temple University Health System on Feb 23, 2022. Temple Health will implement PowerCosting™ from Health Catalyst's Financial Empowerment Suite to enhance financial performance and clinical outcomes. CFO Nick Barcellona emphasized the strategic investment for delivering high-value patient care. This engagement aims to provide insights into true costs and improve resource utilization amidst challenges like shifting payer mixes and rising expenses. Health Catalyst’s CEO Dan Burton expressed confidence in the partnership's potential for measurable healthcare improvements.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.13%
Tags
none
Rhea-AI Summary

Health Catalyst (Nasdaq: HCAT) has announced a definitive agreement to acquire KPI Ninja, a provider of interoperability solutions and population health analytics based in Lincoln, Nebraska. The acquisition is expected to enhance Health Catalyst's data processing capabilities and expand its service offerings. KPI Ninja's technology will integrate seamlessly with Health Catalyst's Data Operating System, empowering clients to build customized clinical solutions. The deal aims to strengthen Health Catalyst's position in the healthcare analytics market, with a focus on uninterrupted service delivery to existing KPI Ninja clients.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.73%
Tags
-
Rhea-AI Summary

Health Catalyst, Inc. (Nasdaq: HCAT) will announce its fourth quarter and full year 2021 operational results on March 1, 2022, after market close. A conference call will follow at 5 p.m. E.T. that day, providing insights into the company's performance. Interested parties can access the call by calling (877) 295-1104 for U.S. participants or (470) 495-9486 for international attendees. The event will be available via a live audio webcast, with a replay accessible shortly after the call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.84%
Tags
conferences earnings
-
Rhea-AI Summary

Health Catalyst, a leading provider of data and analytics technology in healthcare, announced its participation in the 40th Annual J.P. Morgan Healthcare Conference. Key executives including CEO Dan Burton, CFO Bryan Hunt, and SVP Adam Brown will present on January 11, 2022, at 3:45 p.m. ET. An audio replay will be available on their investor relations website. With a cloud-based platform powered by over 100 million patient records, Health Catalyst aims to drive data-informed healthcare improvements for its clients.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.07%
Tags
conferences
Rhea-AI Summary

Health Catalyst, a leader in data and analytics for healthcare, will participate in two investor conferences. CFO Bryan Hunt and SVP Adam Brown will represent the company at the Piper Sandler 33rd Annual Healthcare Conference on December 2, 2021, featuring a fireside chat and meetings. On December 1, 2021, they will also attend the Evercore ISI HealthCONx Conference at 3:30 p.m. EST, which includes a fireside chat and one-on-one meetings. Health Catalyst aims to drive data-informed healthcare improvements using its cloud-based platform, enhancing clinical, financial, and operational outcomes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.09%
Tags
conferences

FAQ

What is the current stock price of Health Catalyst (HCAT)?

The current stock price of Health Catalyst (HCAT) is $1.18 as of March 30, 2026.

What is the market cap of Health Catalyst (HCAT)?

The market cap of Health Catalyst (HCAT) is approximately 80.9M.

HCAT Rankings

HCAT Stock Data

80.94M
64.67M
Health Information Services
Services-computer Programming, Data Processing, Etc.
Link
United States
SOUTH JORDAN

HCAT RSS Feed